Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX – Get Rating) have been given a consensus rating of “Moderate Buy” by the thirteen research firms that are currently covering the company, MarketBeat reports. Two analysts have rated the stock with a hold rating and five have issued a buy rating on the company. The average 1 year […]
Pacira BioSciences, Inc. (NASDAQ:PCRX – Get Rating) has received a consensus rating of “Buy” from the nine brokerages that are presently covering the firm, MarketBeat reports. Two research analysts have rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average twelve-month price target among brokerages that […]